# Safety and Efficacy of MBF-118 in Patients with Crohn Disease

> **NCT05940558** · PHASE2 · COMPLETED · sponsor: **Medibiofarma S.L.** · enrollment: 10 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** MBF-118 oral capsules

## Key facts

- **NCT ID:** NCT05940558
- **Lead sponsor:** Medibiofarma S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-12
- **Primary completion:** 2024-09-10
- **Final completion:** 2024-09-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05940558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05940558, "Safety and Efficacy of MBF-118 in Patients with Crohn Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05940558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*